Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > share activity

<< Previous

Bullboard Posts

Next >>

Comment by Gman620on Aug 18, 2023 5:31pm

239 Views

Post# 35595653

RE:RE:RE:RE:RE:RE:share activity

What is clear to me is that if they don't get a partner soon they will simply run out of money and not be able to raise more at any reasonable valuation. Does pharma care if this treatment can help bladder cancer patients or do they just want to kill off the tech for something more familiar and profitable?

<< Previous

Bullboard Posts

Next >>

These cold weather stocks are looking to heat up for winter